Executive summary of the 2017 KDIGO Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters

Markus Ketteler, Geoffrey A. Block, Pieter Evenepoel, Masafumi Fukagawa, Charles A. Herzog, Linda McCann, Sharon M. Moe, Rukshana Shroff, Marcello A. Tonelli, Nigel D. Toussaint, Marc G. Vervloet, Mary B. Leonard

Research output: Contribution to journalReview articleAcademicpeer-review

Abstract

The KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of CKD-MBD represents a selective update of the prior CKD-MBD Guideline published in 2009. This update, along with the 2009 publication, is intended to assist the practitioner caring for adults and children with chronic kidney disease (CKD), those on chronic dialysis therapy, or individuals with a kidney transplant. This review highlights key aspects of the 2017 CKD-MBD Guideline Update, with an emphasis on the rationale for the changes made to the original guideline document. Topic areas encompassing updated recommendations include diagnosis of bone abnormalities in CKD–mineral and bone disorder (MBD), treatment of CKD-MBD by targeting phosphate lowering and calcium maintenance, treatment of abnormalities in parathyroid hormone in CKD-MBD, treatment of bone abnormalities by antiresorptives and other osteoporosis therapies, and evaluation and treatment of kidney transplant bone disease.

Original languageEnglish
Pages (from-to)26-36
Number of pages11
JournalKidney International
Volume92
Issue number1
DOIs
Publication statusPublished - 1 Jul 2017

Cite this

Ketteler, Markus ; Block, Geoffrey A. ; Evenepoel, Pieter ; Fukagawa, Masafumi ; Herzog, Charles A. ; McCann, Linda ; Moe, Sharon M. ; Shroff, Rukshana ; Tonelli, Marcello A. ; Toussaint, Nigel D. ; Vervloet, Marc G. ; Leonard, Mary B. / Executive summary of the 2017 KDIGO Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update : what's changed and why it matters. In: Kidney International. 2017 ; Vol. 92, No. 1. pp. 26-36.
@article{c19dd3d20d0a4b04bb928347344aaf5f,
title = "Executive summary of the 2017 KDIGO Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters",
abstract = "The KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of CKD-MBD represents a selective update of the prior CKD-MBD Guideline published in 2009. This update, along with the 2009 publication, is intended to assist the practitioner caring for adults and children with chronic kidney disease (CKD), those on chronic dialysis therapy, or individuals with a kidney transplant. This review highlights key aspects of the 2017 CKD-MBD Guideline Update, with an emphasis on the rationale for the changes made to the original guideline document. Topic areas encompassing updated recommendations include diagnosis of bone abnormalities in CKD–mineral and bone disorder (MBD), treatment of CKD-MBD by targeting phosphate lowering and calcium maintenance, treatment of abnormalities in parathyroid hormone in CKD-MBD, treatment of bone abnormalities by antiresorptives and other osteoporosis therapies, and evaluation and treatment of kidney transplant bone disease.",
keywords = "bone mineral density, calcium, dialysis, hyperparathyroidism, hyperphosphatemia, KDIGO CKD-MBD Guideline, kidney transplantation",
author = "Markus Ketteler and Block, {Geoffrey A.} and Pieter Evenepoel and Masafumi Fukagawa and Herzog, {Charles A.} and Linda McCann and Moe, {Sharon M.} and Rukshana Shroff and Tonelli, {Marcello A.} and Toussaint, {Nigel D.} and Vervloet, {Marc G.} and Leonard, {Mary B.}",
year = "2017",
month = "7",
day = "1",
doi = "10.1016/j.kint.2017.04.006",
language = "English",
volume = "92",
pages = "26--36",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "1",

}

Ketteler, M, Block, GA, Evenepoel, P, Fukagawa, M, Herzog, CA, McCann, L, Moe, SM, Shroff, R, Tonelli, MA, Toussaint, ND, Vervloet, MG & Leonard, MB 2017, 'Executive summary of the 2017 KDIGO Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters' Kidney International, vol. 92, no. 1, pp. 26-36. https://doi.org/10.1016/j.kint.2017.04.006

Executive summary of the 2017 KDIGO Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update : what's changed and why it matters. / Ketteler, Markus; Block, Geoffrey A.; Evenepoel, Pieter; Fukagawa, Masafumi; Herzog, Charles A.; McCann, Linda; Moe, Sharon M.; Shroff, Rukshana; Tonelli, Marcello A.; Toussaint, Nigel D.; Vervloet, Marc G.; Leonard, Mary B.

In: Kidney International, Vol. 92, No. 1, 01.07.2017, p. 26-36.

Research output: Contribution to journalReview articleAcademicpeer-review

TY - JOUR

T1 - Executive summary of the 2017 KDIGO Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update

T2 - what's changed and why it matters

AU - Ketteler, Markus

AU - Block, Geoffrey A.

AU - Evenepoel, Pieter

AU - Fukagawa, Masafumi

AU - Herzog, Charles A.

AU - McCann, Linda

AU - Moe, Sharon M.

AU - Shroff, Rukshana

AU - Tonelli, Marcello A.

AU - Toussaint, Nigel D.

AU - Vervloet, Marc G.

AU - Leonard, Mary B.

PY - 2017/7/1

Y1 - 2017/7/1

N2 - The KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of CKD-MBD represents a selective update of the prior CKD-MBD Guideline published in 2009. This update, along with the 2009 publication, is intended to assist the practitioner caring for adults and children with chronic kidney disease (CKD), those on chronic dialysis therapy, or individuals with a kidney transplant. This review highlights key aspects of the 2017 CKD-MBD Guideline Update, with an emphasis on the rationale for the changes made to the original guideline document. Topic areas encompassing updated recommendations include diagnosis of bone abnormalities in CKD–mineral and bone disorder (MBD), treatment of CKD-MBD by targeting phosphate lowering and calcium maintenance, treatment of abnormalities in parathyroid hormone in CKD-MBD, treatment of bone abnormalities by antiresorptives and other osteoporosis therapies, and evaluation and treatment of kidney transplant bone disease.

AB - The KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of CKD-MBD represents a selective update of the prior CKD-MBD Guideline published in 2009. This update, along with the 2009 publication, is intended to assist the practitioner caring for adults and children with chronic kidney disease (CKD), those on chronic dialysis therapy, or individuals with a kidney transplant. This review highlights key aspects of the 2017 CKD-MBD Guideline Update, with an emphasis on the rationale for the changes made to the original guideline document. Topic areas encompassing updated recommendations include diagnosis of bone abnormalities in CKD–mineral and bone disorder (MBD), treatment of CKD-MBD by targeting phosphate lowering and calcium maintenance, treatment of abnormalities in parathyroid hormone in CKD-MBD, treatment of bone abnormalities by antiresorptives and other osteoporosis therapies, and evaluation and treatment of kidney transplant bone disease.

KW - bone mineral density

KW - calcium

KW - dialysis

KW - hyperparathyroidism

KW - hyperphosphatemia

KW - KDIGO CKD-MBD Guideline

KW - kidney transplantation

UR - http://www.scopus.com/inward/record.url?scp=85021339948&partnerID=8YFLogxK

U2 - 10.1016/j.kint.2017.04.006

DO - 10.1016/j.kint.2017.04.006

M3 - Review article

VL - 92

SP - 26

EP - 36

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 1

ER -